⌘K

Login Start Free

Home/Filings/4/0001415889-25-024082

4//SEC Filing

Hurvitz Chaim 4

Accession 0001415889-25-024082

CIK 0001719406other

View on SEC.gov Company Profile

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 3:35 PM ET

Size

5.7 KB

Accession

0001415889-25-024082

Insider Transaction Report

Form 4

Period: 2025-04-09

NRX Pharmaceuticals, Inc.NRXP

Director

Transactions

Award
Stock Option (right to buy)
2025-04-09+25,000→ 25,000 total
Exercise: $1.73Exp: 2035-04-09→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest on April 9, 2026, subject to continued service to the Issuer.

Documents

1 file

4
form4-09102025_070956.xmlPrimary

Issuer

NRX Pharmaceuticals, Inc.

CIK 0001719406

Entity typeother

Related Parties

1

filerCIK 0001630542

Filing Metadata

Form type: 4
Filed: Sep 9, 8:00 PM ET
Accepted: Sep 10, 3:35 PM ET
Size: 5.7 KB

View on SEC.gov